what are the glp-1 agonists receptor increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal The Landscape Of GLP-1 Receptor

More widespread use of SGLT2i in type 1 diabetes will necessitate implementation of strategies to assess and mitigate DKA risk, including preventative measures, patient education and continuous ketone monitoring, as well as a better understanding of the potential benefits for clinical cardiorenal outcomes, especially in high-risk populations such as people with CKD (Table 2) [46, 47]

2021;12:1321 10.3390/mi12111321

Anti-inflammatory eating patterns Given that both Hashimoto's and metabolic dysfunction involve chronic inflammation, an anti-inflammatory dietary approach makes sense

We are real people with real offices, medical providers and registered dietitians, and staff

BMJ Open Diab Res Care

However, challenges include higher costs and limited long-term safety data, necessitating further studies to confirm its cardiovascular benefits in non-diabetic populations and cerebrovascular conditions, such as vascular dementia [15]